Mersana Therapeutics, Inc. lost $0.56 per diluted share in fiscal year 2024. This represents an increase of 62.2% from the prior fiscal year. The table below carries 10 fiscal years, from 2015 to 2024, and the quarters Mersana Therapeutics, Inc. has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Mersana Therapeutics, Inc.'s diluted earnings per share in fiscal year 2024?
Mersana Therapeutics, Inc. lost $0.56 per diluted share in fiscal year 2024.
How fast is Mersana Therapeutics, Inc.'s diluted earnings per share growing?
Mersana Therapeutics, Inc. (MRSN) diluted earnings per share rose by 62.2% year over year, from -$1.48 to -$0.56 in fiscal year 2024.
What was Mersana Therapeutics, Inc.'s diluted earnings per share in the most recent quarter?
Mersana Therapeutics, Inc. (MRSN) reported -$1.51 in diluted earnings per share in Q3 2025.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Mersana Therapeutics, Inc. (MRSN) reported on that line in every period on record.
